RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $816K of Royalty Pharma plc
Sold$815,634
$40.78Price
20,000Shares
−19%Stake
What RPRX did after the filing
- The stock from Wed, Jan 14 open, $40.06
- +14.8%
- S&P 500, same days
- −0.7%
Measured over 30 trading days, to the Feb 27 close.
Traded Fri, Jan 9. Filed Tue, Jan 13, 5:37 PM ET, after the close. Returns use the Jan 14 open and the Feb 27 close. Not investment advice.